Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2269 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

EPA to regulate Nanomaterials

Last week, an EPA administrator told GlobalChem attendees that EPA may soon decide to regulate nanomaterials. According to the official, this rulemaking would be in reaction to a

Vectura obtains E2.5 million milestone payment

VR315 is being developed as a generic product delivered with Vectura’s GyroHaler dry powder inhaler delivery device. Vectura licensed the European rights for VR315 to Sandoz, the generics

Sagia and Emaar sign MoU with Sanofi-Aventis

Pursuant to the terms of the memorandum of understanding (MoU), Sanofi-Aventis is expected to establish its unit in King Abdullah Economic City (KAEC), reportedly the largest private sector